Clinical supply fragility can delay trials, erode value, and expose hidden risks. Strong planning and resilient networks are now critical for success.
- Green Supply Chains Rarely Start With A Pledge; Target Waste Instead
- The Firefighting Era Of Clinical Supply Chain Is Over. Here's What Replaces It
- Navigating FDA Inspections: Practical Steps For Clinical Supply Leaders, Part 2
- Regulatory Readiness In Clinical Supply: Building A Culture Of Compliance, Part 1
- Optimizing Clinical Trial Supply Chains For Epidemic Response
- The High Cost Of Zero Waste: Protecting Patients In Clinical Supply
- From Crisis Response To Repeatable Resilience In Clinical Supply
- Transitioning Into A Clinical Trial Supply Chain Study Lead Role
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
RTSM And Clinical Drug Dispensation
A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.
-
Overcome The Supply Chain Complexities Of Vaccine Development
Explore the industry impact of rapidly evolving vaccinology, the power of next-gen science and technology, and how finding the right supply chain partner has never been more essential.
-
The Dual Sourcing Approach
Having a secondary supplier in place for the manufacturing and packaging of life-saving critical medicines should be an essential part of your strategy in terms of patient health.
-
Advantages Of Robotic Aseptic Processing
Examine the robotic technologies poised to increase manufacturing flexibility and efficiency while minimizing risk when bringing biologics to market.
-
How Clinical Trial Complexity Impacts End Users
This article examines clinical trial complexity through the lens of study investigators, site staff, CRAs, sponsor study and supply managers, and how the RTSM/ IRT provides the ability to be as creative as needed.
-
Top 5 Dos And Don'ts Of RTSM
Discover best practices and common pitfalls for sponsors and vendors in RTSM as well as how to optimize your study by leveraging vendor expertise, avoiding delays, and embracing innovation.
-
Bringing A Biosimilar For Oncology To Market: Injectable Packaging From Early Development To Commercialization
While in their early-stage development of a mAb biosimilar for oncology treatment, a large biopharmaceuticals company sought a packaging recommendation: a stopper to maintain high-quality standards.
-
Powering Complex Personalized Medicine Oncology Trial
Managing custom therapies requires a synchronized supply chain. Learn how to bridge the gap between manufacturing and clinical workflows to ensure seamless patient care in complex oncology trials.
-
24/7 Cell & Gene Control Tower Provides Agile Solution For Critical Shipments
Get an overview of a successful re-route of six critical shipments to the UK and Spain from Amsterdam used to deliver CAR-T drug products to treat non-Hodgkin’s lymphoma cancer patients.
-
My Worst Nightmare In RSTM: Accidental Unblinding
Learn how collaborative efforts from study managers, supply managers, biostatisticians, designers, and clinicians can better protect the blind in clinical trials and prevent accidental unblinding.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.